Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira) Javier MoralesLudwig Merker Review Open access 12 May 2015 Pages: 391 - 403
Absence of Drug–Drug Interactions Between Luseogliflozin, a Sodium–Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males Takashi SasakiYutaka SeinoYoshishige Samukawa Original Research Open access 15 May 2015 Pages: 404 - 417
Evaluation of the Safety Profile of Zolafren®, a Generic Olanzapine Formulation, in Patients with Bipolar Disorder: A Post-Authorization Safety Study Jerzy ChudekMagdalena Olszanecka-GlinianowiczTomasz Gabryelewicz Original Research 15 May 2015 Pages: 418 - 428
Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study Roger S. McIntyreEmmanuelle Weiller Original Research Open access 13 May 2015 Pages: 429 - 444
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a Ali-Frédéric Ben-AmorAnton TrochanovTanya Z. Fischer Original Research Open access 20 May 2015 Pages: 445 - 454
Cost–Utility of First-Line Actinic Keratosis Treatments in Finland Erkki J. SoiniTaru HallinenKari Saarinen Original Research Open access 26 May 2015 Pages: 455 - 476
Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels Adeyinka AbinusawaSrini Tenjarla Original Research Open access 08 May 2015 Pages: 477 - 484
